Skip to main content
An official website of the United States government

Exercise Therapy and Radiation Therapy for the Improvement of Quality of Life in Patients with Metastatic Prostate Cancer

Trial Status: active

This phase II trial compares the effect of exercise therapy and radiation therapy to radiation therapy alone (usual care) in patients with prostate cancer that has spread from where it first started to other places in the body (metastatic). Each year, 30,000 men in the United States (U.S.) are diagnosed with metastatic prostate cancer. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Radiation therapy is critical in the care of these men because it lowers pain and slows tumor growth. Nonetheless, men with metastatic prostate cancer who are receiving radiation therapy typically live less than 2 years. Additionally, radiation therapy has side effects, which lower quality of life. Quality of life can predict how long patients can live, so if this metric can be improved, then their survival time may also improve. Exercise therapy has been shown to improve quality of life for cancer patients receiving chemotherapy. The combination of exercise therapy and radiation therapy for men with prostate cancer receiving radiation has never been studied. Giving exercise therapy and radiation therapy may improve quality of life and reduce the side effects of the radiation compared to radiation alone in patients with metastatic prostate cancer.